May 3, 2020 • 1HR 56M

Episode 7 - 5.3.2020

 
1.0×
0:00
-1:56:00
Open in playerListen on);
What Happens Next offers listeners an in-depth investigation of the most pressing issues of the day. Visit https://www.whathappensnextin6minutes.com/ for all the links and to subscribe
Episode details
Comments

Dr. Ofer Levy

Topic: Vaccines
Bio: Ofer Levy MD, PhD is a physician-scientist who directs the Precision Vaccines Program at Boston Children’s Hospital. He is a Professor of Pediatrics at Harvard Medical School and Associate Member of the Broad Institute of MIT & Harvard.

1.0×
0:00
-8:58


Madeleine Grynsztejn

Topic: Managing a Contemporary Art Museum during a pandemic

1.0×
0:00
-6:55

Madeleine Grynsztejn QA

1.0×
0:00
-3:15


Angela Duckworth

Topic: Will GRIT improve your odds of success with Covid19?
Bio: Founder and CEO of Character Lab, a nonprofit whose mission is to advance scientific insights that help children thrive. She is also a professor of psychology at the University of Pennsylvania and in 2013 was named a MacArthur Fellow.

1.0×
0:00
-6:48

Angela Duckworth QA

1.0×
0:00
-4:40


Dr. Steve Fallek

Topic: When can we do elective surgery (and I don’t mean a colonoscopy)
Bio: Steve is the current President of the New Jersey Society of Plastic Surgeons and a Past President of the New York Regional Society of Plastic Surgeons. He is a member of the Northeast Regional Task Force Coalition formulating the Guidelines for Restarting Elective Surgery Post-COVID-19. He is in private practice in NYC and NJ and a co-owner of BeautyFix Med Spa in NYC

1.0×
0:00
-7:32

Dr. Steve Fallek QA

1.0×
0:00
-4:12


Scott Galloway

Topic: Staying Motivated Now
Bio: Professor of Marketing at NYU Stern School of Business where he teaches Brand Strategy and Digital Marketing to second-year MBA students and is the author of the Digital IQ Index, a global ranking of prestige brands’ digital competence.

1.0×
0:00
-8:21

Scott Galloway QA

1.0×
0:00
-4:34


Dr. Daniel Berger

Topic: Covid19 Treatments: Lessons learned from HIV
Bio: A leading HIV specialist in the U.S. He is Clinical Associate Professor at the College of Medicine, University of Illinois at Chicago and medical director and founder of Northstar Medical Center, the largest private HIV treatment and research center in the Greater Chicago area. Dr. Berger serves as principal investigator at Northstar Medical Center where he has conducted nearly 200 HIV-related clinical trials. Dr. Berger is well known nationally and internationally among researchers and individuals engaged in HIV drug development. He has published more than 70 articles and abstracts in peer-reviewed medical journals and international conferences on antiretroviral therapy and other HIV-related treatments.

1.0×
0:00
-6:28

Dr. Daniel Berger QA

1.0×
0:00
-7:12


Stuart Buck

Topic: Bad Science and Covid19
Bio: VP of Research at Arnold Ventures. Ph.D. in education policy from the University of Arkansas; a J.D. with honors from Harvard Law School, where he was an editor of the Harvard Law Review

1.0×
0:00
-6:50

Stuart Buck QA

1.0×
0:00
-2:41


Ashoka Mody

Topic: Pandemic and the EU
Bio: Charles and Marie Robertson Visiting Professor in International Economic Policy at the Woodrow Wilson School, Princeton University. He is author of EuroTragedy: A Drama in Nine Acts. Previously, Professor Mody was Deputy Director in the International Monetary Fund’s Research and European Departments.

1.0×
0:00
-8:13

Ashoka Mody QA

1.0×
0:00
-2:29


Bob Maricich

Topic: How will the furniture industry survive Covid19?
Bio: Chairman and CEO of International Market Centers

1.0×
0:00
-6:36

Bob Maricich QA

1.0×
0:00
-0:55


Tim Schoen

Topic: Real Estate the Life Science Industry
Bio: President and CEO of BioMed, which owns 11.2mm SQF of Life Science Real Estate

1.0×
0:00
-7:50


Steve Greenbaum

Topic: Senior Housing and Covid19
Bio: Since 2004, Steve has focused exclusively on the preservation of affordable housing for income-restricted seniors around the country. He personally holds ownership interests in 19 different affordable senior properties with an average property size of 112 units. These buildings benefit from federal affordable housing programs including Section 42 Low-Income Housing Tax Credits (LIHTC), tax-exempt multifamily bonds, HOME funds

1.0×
0:00
-10:32


Questions for Speakers

1.0×
0:00
-30:19